When: Pullback to $53.40-$54.00 with RSI <30 and capitulation volume

Then: Defensive add with stop at $51.00

HOLD at benchmark weight, trim overweight positions on rallies toward 50 SMA at 61.38, sell call spreads into late October earnings to finance downside protection, no new initiations

• Operating income declined 31% year-over-year from Q2 2025 (1.172 billion) to Q2 2026 (808 million), and net income was flat at 560 million in both Q1 and Q2 2026 versus 641 million in Q2 2025 and 743 million in Q3 2025
• H2 recovery requires ~1.24 EPS per quarter versus 0.44 per quarter actually delivered in H1, representing nearly 3x the run rate needed amid strong dollar, sticky input costs, and zero Fed easing probability
• Net debt of 19.5 billion with interest expense up 8% YoY; Q1 2026 interest expense of 148 million is the leading edge as debt refinances into higher rates over 12-24 months
• Trailing free cash flow of 2.25 billion against 3.4 billion annual capital returns creates unsustainable math without continued debt issuance or asset sales
• Technical indicators show broken medium-term trend: 50 SMA at 61.38 rolling over, MACD deeply negative at negative 91 basis points, RSI bounced to 37 from below 30; ATR compressed from 1.68 to 1.15 and MACD histogram improved from negative 34 to negative 26, but this is deceleration of downside momentum, not confirmed reversal
• Q3 earnings in late October is a binary catalyst; if management guides down or forward EPS revises from 3.36 toward 2.72 trailing, the stock could gap to mid-50s (10-12% below current) in a single session
• Aggressive analyst's stop at 57.17 is 15 cents inside the lower Bollinger band at 57.38, offering inadequate protection given 4-6% measured move target to 55-56 on a close below support
• Quiet order books with no news flow represent a vacuum that fills in both directions; lack of bearish positioning going into Q3 print means no one to lean against the trade on a downside catalyst

→ vs aggressive: Seasonal normalization argument underestimates independent headwinds: strong dollar, sticky input costs, and zero Fed easing odds must all resolve simultaneously for H2 recovery to materialize, which is a recovery trade requiring every variable to go right rather than a seasonal normalization trade

→ vs aggressive: Leverage treated as a feature when it is a structural constraint: 8% YoY increase in interest expense on 19.5 billion net debt with 96% probability of zero Fed cuts in 2026 and ten-year at highest level since 2002 means refinancing costs will flow directly through the income statement over next 12-24 months

→ vs aggressive: Silence-as-contrarian-signal logic is flawed: absence of bearish news on a name trading at 200-day moving average with RSI at 37 creates a vacuum that fills in both directions, not bullish confirmation, and lack of bearish positioning going into Q3 earnings means no counterparty to absorb a downside gap

→ vs aggressive: Coiled spring technical argument confuses decelerating downside momentum with actual reversal: 50 SMA rolling over, lower highs since August, and MACD still deeply negative at negative 91 basis points indicate broken medium-term trend, not a bounce off support

Maintain benchmark weighting without adding or trimming; use collar on existing shares to hedge binary catalyst rather than directional positions; hard invalidation at 57.17 daily close on heavy volume

• Technical setup has coiled-spring characteristics with ATR compression from 1.68 to 1.15, MACD histogram improving, and RSI bouncing off extreme oversold
• Beta of 0.39 provides structural portfolio protection; 3.56% yield provides real carry compensation for waiting
• 50 SMA at 61.38 is rolling over with lower highs since August; MACD line still at negative 0.91 indicating momentum has rolled over, not reversed
• MACD histogram improvement from negative 0.34 to negative 0.26 is deceleration of selling pressure, not price confirmation
• 31% year-over-year operating income decline with net income at 560 million in both Q1-Q2 2026 versus 743 million in Q3 2025 creates three consecutive quarters of margin compression
• Consensus forward EPS of 1.24 per quarter is plausible scenario requiring cocoa normalization, seasonal mix, and pricing actions to deliver normal recovery pattern
• Interest expense up 8% year-over-year but manageable given 72% dividend payout ratio and 2.25 billion TTM free cash flow coverage
• Invalidation level at 57.17 daily close on heavy volume signals coiled spring broke downward with measured move toward 55-56 in play
• Position should ride at support rather than trim; rallies toward 50 SMA at 61.38 are better trim levels than current prices

→ vs aggressive: Frame is seductively dangerous - calling MACD histogram improvement a reversal setup when MACD line at negative 0.91 is momentum rolled over in no-man's land, not confirmation the knife stopped falling

→ vs aggressive: Overreaches on seasonal argument by hand-waving away 31% operating income decline as 'lapping front-loaded pricing' when three headwinds (input costs, FX, operating leverage) must all reverse simultaneously

→ vs aggressive: Dangerous use of silence-as-contrarian-signal - absence of bearish news flow doesn't indicate directional catalyst break; vacuum doesn't tell you which direction

→ vs conservative: EPS gap framing is intellectually dishonest - gap is scenario requiring cocoa normalization and seasonal mix, not an impossible outcome; defensive rotation tailwind exists

→ vs conservative: Leverage argument oversimplifies - Mondelez has managed capital structure through prior rate cycles; 2.25B TTM FCF and 72% payout ratio provide buffer within structural parameters

→ vs conservative: Selling call spreads into earnings presumes directional certainty about disappointment - that's not neutral, that's a different kind of aggression disguised as prudence